Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-26 @ 3:04 AM
Study NCT ID:
NCT00644020
Status:
UNKNOWN
Last Update Posted:
2008-03-26
First Post:
2008-03-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients
Sponsor:
Shenzhen Kangzhe Pharmaceutical Co., Ltd.